Applied DNA Sciences Reports Fiscal Fourth Quarter and Year End Results

Go back to Applied DNA Sciences Reports Fiscal Fourth Quarter and Year End Results

Applied DNA Sciences (APDN) Misses Q4 EPS by 1c

December 7, 2016 6:29 AM EST

Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.79 million.

Excluding non-cash expenses, Adjusted EBITDA for the quarter ended September 30, 2016 was negative $1.7 million... More